Fundação Antônio Prudente - CAPEC - Centro de Apoio à Pesquisa Clínica
Fundação Antônio Prudente - CAPEC - Centro de Apoio à Pesquisa Clínica
R. Prof. Antônio Prudente, 212 - Liberdade, São Paulo - SP, 01509-010
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Guilherme Calvacante
Nicolly Muller
Jayr Filho
Tatiany Barreto Aguiar de Souza
Humberto Silva
Open studies
Multiple myeloma
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) - SUCCESSOR-2 - Bristol-Myers SquibbSee more
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma - MajesTEC-9 - Janssen Research & Development, LLCSee more
Non-Hodgkin Lymphoma
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma - EPCORE FL-1 - AbbVieSee more
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - EPCORE DLBCL-2 - AbbVieSee more
Lung cancer
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer - PolyDamas - Janssen Research & Development, LLCSee more
Lymphoma
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma - EPCORE FL-1 - AbbVieSee more
